Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,770 | 66 | 95.7% |
| Education | $78.99 | 1 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $417.32 | 12 | $0 (2024) |
| Boston Scientific Corporation | $257.85 | 10 | $0 (2022) |
| Vapotherm Inc | $186.78 | 9 | $0 (2022) |
| Mallinckrodt Hospital Products Inc. | $119.74 | 1 | $0 (2020) |
| Astellas Pharma US Inc | $113.04 | 5 | $0 (2017) |
| Actelion Pharmaceuticals US, Inc. | $104.65 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $82.81 | 6 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $78.82 | 3 | $0 (2024) |
| Ambu Inc. | $62.96 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $61.38 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $415.21 | 14 | Actelion Pharmaceuticals US, Inc. ($104.65) |
| 2023 | $173.95 | 7 | Regeneron Healthcare Solutions, Inc. ($33.03) |
| 2022 | $154.72 | 7 | Boston Scientific Corporation ($70.73) |
| 2021 | $45.34 | 2 | BOSTON SCIENTIFIC CORPORATION ($45.34) |
| 2020 | $295.57 | 9 | Vapotherm Inc ($126.61) |
| 2019 | $146.50 | 6 | Boston Scientific Corporation ($92.56) |
| 2018 | $224.08 | 8 | PFIZER INC. ($182.77) |
| 2017 | $393.72 | 14 | PFIZER INC. ($197.76) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $27.63 | General |
| 11/18/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $30.58 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 11/07/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Respiratory | ||||||
| 11/01/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $33.34 | General |
| 10/08/2024 | Fisher & Paykel Healthcare Inc | FISHER & PAYKEL HEALTHCARE (Device), FISHER & PAYKEL HEALTHCARE, FISHER & PAYKEL HEALTHCARE | Food and Beverage | In-kind items and services | $41.11 | General |
| Category: Nasal High Flow | ||||||
| 09/13/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $22.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: RESPIRATORY | ||||||
| 08/09/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $78.99 | General |
| Category: Cardiology | ||||||
| 08/01/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: Cardiology | ||||||
| 06/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: RESPIRATORY | ||||||
| 06/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: RESPIRATORY | ||||||
| 04/18/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $29.62 | General |
| 03/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/06/2024 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/14/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Inflammation | ||||||
| 12/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: RESPIRATORY | ||||||
| 12/01/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $18.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2023 | 3B Medical, Inc. | LUNA (Device) | Food and Beverage | Cash or cash equivalent | $20.67 | General |
| Category: VENTILATOR, NON-CONTINUOUS (RESPIRATOR) | ||||||
| 09/07/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Respiratory | ||||||
| 06/29/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV | Food and Beverage | In-kind items and services | $30.70 | General |
| 06/09/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.03 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/16/2022 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: EXALT_ENDO | ||||||
| 06/02/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/01/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/05/2022 | Boston Scientific Corporation | ZOOM Wireless Transmitter (Device) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: ZOOM_CRM | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 643 | 1,330 | $421,667 | $134,342 |
| 2022 | 7 | 657 | 1,335 | $333,840 | $110,569 |
| 2021 | 10 | 806 | 1,772 | $425,013 | $169,587 |
| 2020 | 10 | 744 | 1,491 | $361,345 | $142,885 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 201 | 660 | $225,760 | $71,309 | 31.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 169 | 357 | $78,540 | $25,619 | 32.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 89 | 100 | $50,800 | $15,824 | 31.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 102 | 107 | $40,217 | $12,677 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 37 | $7,350 | $2,859 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 19 | $5,720 | $2,245 | 39.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 22 | 22 | $5,060 | $1,627 | 32.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 11 | 11 | $3,630 | $1,157 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 17 | $4,590 | $1,025 | 22.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 229 | 594 | $118,800 | $39,852 | 33.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 125 | 387 | $112,230 | $37,297 | 33.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 145 | 154 | $46,200 | $15,121 | 32.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 58 | 59 | $23,010 | $7,604 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 31 | $8,860 | $3,421 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 35 | $6,890 | $2,830 | 41.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 16 | 24 | $8,880 | $2,043 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 17 | 21 | $5,670 | $1,280 | 22.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 17 | 30 | $3,300 | $1,122 | 34.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 169 | 812 | $196,504 | $79,606 | 40.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 264 | 277 | $88,363 | $35,878 | 40.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 216 | 494 | $83,486 | $33,785 | 40.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 13 | 15 | $7,800 | $3,200 | 41.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 35 | $6,125 | $3,123 | 51.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 25 | 31 | $7,905 | $2,592 | 32.8% |
| 31622 | Diagnostic examination of lung airways using an endoscope | Facility | 2021 | 14 | 19 | $9,025 | $2,488 | 27.6% |
About Dr. William Pascal, MD
Dr. William Pascal, MD is a Critical Care Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558474627.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Pascal, MD has received a total of $1,849 in payments from pharmaceutical and medical device companies, with $415.21 received in 2024. These payments were reported across 67 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,770).
As a Medicare-enrolled provider, Pascal has provided services to 2,850 Medicare beneficiaries, totaling 5,928 services with total Medicare billing of $557,382. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Brooklyn, NY
- Active Since 08/16/2006
- Last Updated 09/11/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558474627
Products in Payments
- ELIQUIS (Drug) $385.10
- Precision Flow (Device) $161.30
- ACTHAR (Biological) $119.74
- Ambisome (Drug) $113.04
- OPSUMIT (Drug) $78.99
- TRELEGY ELLIPTA (Drug) $61.38
- LATITUDE (Device) $52.45
- EXALT Model D (Device) $48.43
- TEZSPIRE (Biological) $48.01
- LUX-DX (Device) $45.34
- System One (Device) $45.00
- ZERBAXA (Drug) $41.31
- FISHER & PAYKEL HEALTHCARE (Device) $41.11
- CLEVIPREX (Drug) $40.71
- XARELTO (Drug) $39.51
- DUPIXENT (Biological) $33.03
- CHANTIX (Drug) $32.22
- Kcentra (Biological) $30.58
- UPTRAVI (Drug) $25.66
- VAPOTHERM (Device) $25.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Brooklyn
Dr. Joshua Rosenberg, M.d, M.D
Critical Care Medicine — Payments: $893,165
Dr. Aaliya Burza, M.d, M.D
Critical Care Medicine — Payments: $54,441
Dr. Keerthana Keshava, M.b.b.s, M.B.B.S
Critical Care Medicine — Payments: $23,722
Dr. Yizhak Kupfer, Md, MD
Critical Care Medicine — Payments: $22,120
Mediha Ibrahim, M.d, M.D
Critical Care Medicine — Payments: $14,961
Igor Chernyavskiy, M.d, M.D
Critical Care Medicine — Payments: $7,598